The fatty acid compositions of erythrocyte and plasma polar lipids in children with autism, developmental delay or typically developing controls and the effect of fish oil intake

British Journal of Nutrition

Volumn 103, Issue 8, 2010, Pages 1160-1167

  Gordon Bell, John ^a   Miller, Deborah ^b   MacDonald, Donald J ^c   MacKinlay, Elizabeth E ^a   Dick, James R ^a   Cheseldine, Sally ^d   Boyle, Rose M ^c   Graham, Catriona ^e   O'Hare, Anne E ^b  

^a UNIVERSITY OF STIRLING   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c VICTORIA INFIRMARY   (United Kingdom)

^d CFMHS   (United Kingdom)

^e WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Autism; Blood fatty acids; Child health; Fish oils; N 3 Highly unsaturated fatty acids

Indexed keywords

ARACHIDONIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LIPID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID; SHORT CHAIN FATTY ACID; FATTY ACID;

ARTICLE; AUTISM; BLOOD ANALYSIS; BLOOD SAMPLING; CHILD; CHILD DEVELOPMENT; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DIET SUPPLEMENTATION; ERYTHROCYTE LEVEL; FEMALE; FOOD COMPOSITION; HUMAN; LIPID ANALYSIS; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; MYELIN SHEATH; NERVE FIBER; SCHOOL CHILD; ATTENTION DEFICIT DISORDER; BLOOD; CASE CONTROL STUDY; DRUG EFFECT; ERYTHROCYTE; METABOLISM; REFERENCE VALUE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD; DEVELOPMENTAL DISABILITIES; ERYTHROCYTES; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; FISH OILS; HUMANS; LIPIDS; REFERENCE VALUES;

EID: 77951626685     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509992881     Document Type: Article

References (53)

1. Baird G, Simonoff E, Pickles A, et al. (2006) Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 368, 210-215.
2. Harrison MJ, O'Hare AE, Campbell H, et al. (2006) Prevalence of autistic spectrum disorders in Lothian, Scotland an estimate using the 'capture-recapture' technique. Arch Dis Child 91, 16-19.
3. Baron-Cohen S, Scott FJ, Alison C, et al. (2009) Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psych 194, 500-509.
4. Blaxhill MF, Baskin DS & Spitzer WO (2003) The changing prevalence of autism in California. J Autism Dev Disorders 33, 223-226.
5. Richardson AJ & Ross MA (2000) Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot Essent Fatty Acids 63, 1-9.
6. Young G & Conquer J (2005) Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev 45, 1-28.
7. Horrobin DF & Bennett CN (2003) Phospholipid metabolism and the pathophysiology of psychiatric and neurodevelopmental disorders. In Phospholipid Spectrum Disorders in Psychiatry and Neurology, pp. 3-47 [M Peet, IAM Glen and DF Horrobin, editors]. Carnforth: Marius Press.
8. Uauy R & Dangour AD (2006) Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev 64, S24-S33.
9. Ruxton CHS, Calder PC, Reed SC, et al. (2005) The impact of long-chain n-3 polyunsaturated fatty acids on human health. Nutr Res Rev 18, 113-129.
10. Sprecher H (1999) An update on the pathways of polyunsatu-rated fatty acid metabolism. Curr Opin Clin Nutr Metab Care 2, 135-138.
11. Pawolsky RJ, Hibbeln JR, Novotny JA, et al. (2001) Physiological compartmental analysis of a-linolenic acid metabolism in adult humans. J Lipid Res 42, 1257-1265.
12. Burdge GC, Jones AE & Wootton SA (2002) Eicosapentaenoic and docosapentaenoic acids are the principal products of a-linolenic acid metabolism in young men. Br J Nutr 88, 355-363.
13. Burdge GC & Wootton SA (2002) Conversion of a-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexa-enoic acids in young women. Br J Nutr 88, 411-420.
14. Constantino JN & Todd RD (2003) Autistic traits in the general population: a twin study. Arch Gen Psychiatry 60, 524-530.
15. Kim HY (2007) Novel metabolism of docosahexaenoic acid in neural cells. J Biol Chem 282, 18661-18665.
16. Orr SK & Bazinet RP (2008) The emerging role of docosahexaenoic acid in neuroinflammation. Curr Opinion Invest Drugs 9, 735-743.
17. Bazan NG (2005) Lipid signalling in neural plasticity, brain repair, and neuroprotection. Mol Neurobiol 32, 89-103.
18. Brookes KJ, Chen W, Xu X, et al. (2006) Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol Psychiatry 60, 1053-1061.
19. Scaeffer L, Gohlke H, Muller M, et al. (2006) Common genetic variants of the FADS1 FADS 2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Human Mol Genetics 15, 1745-1756.
20. Vancassel S, Durand G, Barthelemy C, et al. (2001) Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids 65, 1-7.
21. 2 in autistic spectrum disorders. Prostaglandins Leukot Essent Fatty Acids 71, 201-204.
22. Bu B, Ashwood P, Harvey D, et al. (2006) Fatty acid compositions of red blood cell phospholipids in children with autism. Prostaglandins Leukot Essent Fatty Acids 74, 215-221.
23. Lord C, Rutter M & Le Couteur A (1994) Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for care givers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24, 659-685.
24. Scottish Intercollegiate Guidelines Network (2007) Guideline 98: Assessment, diagnosis and clinical interventions for children and young people with autism spectrum disorders: a national clinical guideline. http://www.sign.ac.uk/guidelines/fulltext/98/index.html (accessed 30 April 2009).
25. World Health Organization (1993) The ICD-10 Classification of Mental and Behavioural Disorders-Diagnostic Criteria for Research. Geneva, Switzerland: WHO.
26. American Psychiatric Association (1994) Diagnostic and Statistical Manual for Mental Disorders (DSM-IV), 4th ed. Washington, DC: APA.
27. Harrison MJ, O'Hare AE, Campbell H, et al. (2006) Prevalence of autistic spectrum disorders in Lothian, Scotland and estimated using the capture-recapture technique. Arch Dis Child 91, 16-19.
28. Goodman R, Ford T & Simmons H (2000) Using the Strengths and Difficulties Questionnaire (SDQ) to screen for child psychiatric disorders in a community sample. Br J Psychiatry 177, 534-539.
29. Sparrow SS & Cicchetti DV (1985) Diagnostic uses of the Vineland Adaptive Behaviour Scales. J Pediatr Psychol 10, 215-225.
30. Bligh EG & Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911-917.
31. Folch J, Lees M & Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
32. Christie WW (2003) Preparation of derivatives of fatty acids. In Lipid Analysis, 3rd ed., pp. 205-224 [PJ Barnes, editor]. Bridgwater, UK: The Oily Press.
33. Aupperle RL, Denney DR, Lynch SG, et al. (2008) Omega-3 fatty acids and multiple sclerosis: relationship to depression. J Behav Med 31, 127-135.
34. Clayton EH, Hanstock TL, Hirneth SJ, et al. (2008) Long-chain omega-3 polyunsaturated fatty acids in the blood of children and adolescents with juvenile bipolar disorder. Lipids 43, 1031-1038.
35. Cyhlarova E, Bell JG, Dick JR, et al. (2007) Membrane fatty acids, reading and spelling in dyslexic and non-dyslexic adults. Eur Neuropsychopharmacol 17, 116-121.
36. Calder PC (2003) n-3 Polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38, 342-352.
37. Galli C, Marangoni F & Petroni A (1992) Modulation of arachidonic acid metabolism in cultured rat astroglial cells by long-chain n-3 fatty acids. Adv Exp Med Biol 318, 115-120.
38. Jump DB (2002) The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 277, 8755-8758.
39. Allessandri J-M, Guesnet P, Vancassel S, et al. (2004) Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod Nutr Dev 44, 509-548.
40. Ledeen RW, Yu RK & Eng LF (1973) Gangliosides of human myelin: sialosyl galactosylceramide (G7) as a major component. J Neurochem 21, 829-839.
41. Clark-Taylor T & Clark-Taylor BE (2004) Is autism a disorder of fatty acid metabolism? Possible dysfunction of mito-chondrial b-oxidation by long chain acyl-CoA dehydrogenase. Med Hypotheses 62, 970-975.
42. Shao L, Martin MV, Watson SJ, et al. (2008) Mito-chondrial involvement in psychiatric disorders. Ann Med 40, 281-295.
43. Stevens L, Zhang W, Peck L, et al. (2003) EFA supplementation in children with inattention, hyperactivity and other disruptive behaviours. Lipids 38, 1007-1021.
44. Panchaud A, Sauty A, Kernan Y, et al. (2006) Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial. Clin Nutr 25, 418-427.
45. Katan MB, Deslypere JP, van Birgelen AP, et al. (1997) Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18 month controlled study. J Lipid Res 38, 2012-2022.
46. Stevens LJ, Zental SS, Deck JL, et al. (1995) Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 62, 761-768.
47. Puri B & Richardson AJ (2003) Long-term follow up of a single patient with schizophrenia treated with ethyl-EPA alone. In Phospholipid Spectrum Disorders in Psychiatry and Neurology, pp. 377-390 [M Peet, IAM Glen and DF Horrobin, editors]. Carnforth, UK: Marius Press.
48. Herndon AC, Di Guiseppi C, Johnson SL, et al. (2009) Does nutritional intake differ between children with autism spectrum disorders and children with typical development? J Autism Dev Disord 39, 212-222.
49. Pontes PV, Torres AG, Trugo NMF, et al. (2006) n-6 and n-3 Long-chain polyunsaturated fatty acids in the erythrocyte membrane of Brazilian preterm and term neonates and their mothers at delivery. Prostaglandins Leukot Essent Fatty Acids 74, 117-123.
50. Smithers LG, Gibson RA, McPhee A, et al. (2008) Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukot Essent Fatty Acids 79, 141-146.
51. Bent S, Bertoglio K & Hendren RL (2009) Omega-3 fatty acids for autistic spectrum disorder: a systematic review. J Autism Dev Disord 39, 1145-1154.
52. Moriguchi T, Greiner RS & Salem N Jr (2000) Behavioural deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem 75, 2563-2573.
53. Richardson AJ & Puri BK (2002) A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsy-chopharmacol Biol Psychiatry 26, 233-239.